Immunological Landscape of Neuroblastoma and Its Clinical Significance
Overview
Authors
Affiliations
Immune infiltration in neuroblastoma (NBL) has been associated with clinical outcome. However, the diversity of distinct immune subpopulations that comprise immune infiltrates in NBL has not been examined. To this end, the present study investigated the immunological landscape of NBL tumors and its clinical significance. CIBERSORTx, an established RNA deconvolution algorithm, was used to impute immune cell proportions from 153 primary NBL tumors. Associations between immune proportions and overall/event-free survival were analyzed by Kaplan-Meier curves and evaluated using log-rank test. Of the 22 subpopulations imputed, M2 macrophages were the most abundant subtype in NBL tumors. Furthermore, monocytes, CD4+ naïve T cells, and CD4+ activated memory T cells were significantly associated with survival. Altogether, the findings suggest differences amongst certain immune cell subsets comprising NBL tumor infiltration and these differences may be important determinants of prognosis.
The neuroblastoma tumor microenvironment: From an in-depth characterization towards novel therapies.
Louault K, De Clerck Y, Janoueix-Lerosey I EJC Paediatr Oncol. 2024; 3.
PMID: 39036648 PMC: 11259008. DOI: 10.1016/j.ejcped.2024.100161.
Wu X, Mi T, Jin L, Ren C, Wang J, Zhang Z Cancer Immunol Immunother. 2024; 73(7):122.
PMID: 38714539 PMC: 11076449. DOI: 10.1007/s00262-024-03702-9.
Tian X, Li H, Luo T, Mao J, Yuan X, Gao Q Transl Pediatr. 2024; 12(12):2232-2246.
PMID: 38197110 PMC: 10772832. DOI: 10.21037/tp-23-545.
Targeting the myeloid microenvironment in neuroblastoma.
Stip M, Teeuwen L, Dierselhuis M, Leusen J, Krijgsman D J Exp Clin Cancer Res. 2023; 42(1):337.
PMID: 38087370 PMC: 10716967. DOI: 10.1186/s13046-023-02913-9.
Chu J Front Genet. 2022; 13:947000.
PMID: 35991559 PMC: 9389598. DOI: 10.3389/fgene.2022.947000.